The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review

INTRODUCTION: Few studies have described their experience using esmolol, an ultra-short acting β-adrenergic antagonist, in the emergency department (ED) as a feasible adjuvant therapy for the treatment of refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Miraglia, Dennis, Miguel, Lourdes A., Alonso, Wilfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130434/
https://www.ncbi.nlm.nih.gov/pubmed/32259114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130434/
https://www.ncbi.nlm.nih.gov/pubmed/32259114

Ejemplares similares